{"meshTagsMajor":["Genes, BRCA2"],"meshTags":["Risk Factors","United States","Carcinoma, Ductal, Breast","Genes, BRCA2","Humans","Genetic Predisposition to Disease","Breast Neoplasms, Male","Risk Assessment","Incidence","Male"],"meshMinor":["Risk Factors","United States","Carcinoma, Ductal, Breast","Humans","Genetic Predisposition to Disease","Breast Neoplasms, Male","Risk Assessment","Incidence","Male"],"genes":["BRCA2"],"publicationTypes":["Journal Article","Review"],"abstract":"Although male breast cancer (MBC) is rare (\u003c1% of all BC), its reported incidence has been rising. In addition to traditional risk factors, there is now known to be a 7% life-time risk in carriers of BRCA2. This article discusses the clinical and histological presentation of MBC and reviews the main treatments.","title":"Male breast cancer.","pubmedId":"15633473"}